INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹47 Cr | ₹114 Cr | ₹-430 Cr | ₹370 Cr | ₹16 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDEGENE ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹47 Cr |
Mar2024 | ₹114 Cr |
Mar2023 | ₹-430 Cr |
Mar2022 | ₹370 Cr |
Mar2021 | ₹16 Cr |
How is Net Cash Inflow / Outflow of INDEGENE Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹47 Cr | -59.14 | |
Mar2024 | ₹114 Cr | Positive | |
Mar2023 | ₹-430 Cr | Negative | |
Mar2022 | ₹370 Cr | 2,174.92 | |
Mar2021 | ₹16 Cr | - |
Compare Net Cash Inflow / Outflow of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,332.8 Cr | -1.1% | -3.4% | -4.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -1.1% |
-3.4% |
-4.1% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses